Claims for Patent: 7,741,098

Summary for Patent: 7,741,098

Title:	Production of eukaryotic proteins and nucleic acid molecules in C. elegans
Abstract:	Plasmid vectors for expression in Caenorhabditis elegans harbouring a heat inducible promoter nucleotide sequence, a synthetic intron nucleotide sequence optionally containing a Shine-Dalgarno sequence for efficient shuttling between C. elegans and E. coli, optionally a nucleotide sequence coding for a nuclear localisation signal or secretion signal, a nucleotide sequence coding for a recognizable tag, optionally a nucleotide sequence coding for a fluorescent protein, a nucleotide sequence coding for a protease cleavage site, a multiple cloning site containing a nucleotide sequence coding for an eukaryotic, such as human, protein or a nucleic acid molecule and a nucleotide sequence coding for termination of translation, are described. Methods of particularly large scale production of eukaryotic, such as human, proteins and nucleic acid molecules in nematodes are also described.
Inventor(s):	Sauer; Uwe H (Umea, SE), Tuck; Simon (Umea, SE)
Assignee:	neXyte AB (Umea, SE)
Application Number:	10/496,767
Patent Claims:	1. Plasmid vector for expression in Caenorhabditis elegans and in Escherichia coli comprising in the 5' to 3' direction of transcription operably linked to each other a heat shock promoter nucleotide sequence, a synthetic intron nucleotide sequence containing a Shine-Dalgarno sequence, optionally a nucleotide sequence coding for a nuclear localization signal or a secretion signal, a nucleotide sequence coding for a recognizable tag, optionally a nucleotide sequence coding for a fluorescent protein, a nucleotide sequence coding for a protease cleavage site, a multiple cloning site containing a nucleic acid molecule or a nucleotide sequence coding for a eukaryotic protein, and a nucleotide sequence coding for termination of translation so as to express a eukaryotic protein or nucleic acid molecule in Caenorhabditis elegans and in Escherichia coli wherein the synthetic intron nucleotide sequence contains the Shine-Dalgarno sequence AGGAG, the nucleotide sequence coding for a nuclear localization signal is SEQ ID NO: 3, the sequence coding for a recognizable tag is a sequence coding for a 6-Histidine (His), 10-His or 12-His tag, the nucleotide sequence coding for a fluorescent protein is a nucleotide sequence coding for the green fluorescent protein with the sequence SEQ ID NO: 8, the nucleotide sequence coding for a protease cleavage site is a sequence coding for a Tobacco Etch Virus (TEV) protease cleavage site. 2. Plasmid vector according to claim 1, wherein the nucleotide sequence order is modified so that the multiple cloning site is followed by the nucleotide sequence coding for a protease cleavage site, the optional nucleotide sequence coding for a fluorescent protein, optionally the nucleotide sequence coding for a nuclear localization signal or a secretion signal and the nucleotide sequence coding for a recognizable tag. 3. Plasmid vector for expression in Caenorhabditis elegans and in Escherichia coli comprising in the 5' to 3' direction of transcription operably linked to each other a heat shock promoter nucleotide sequence, a synthetic intron nucleotide sequence containing a Shine-Dalgarno sequence, optionally a nucleotide sequence coding for a nuclear localization signal or a secretion signal, a nucleotide sequence coding for a recognizable tag, optionally a nucleotide sequence coding for a fluorescent protein, a nucleotide sequence coding for a protease cleavage site, a multiple cloning site containing a nucleic acid molecule or a nucleotide sequence coding for a eukaryotic protein, and a nucleotide sequence coding for termination of translation so as to express a eukaryotic protein or nucleic acid molecule in Caenorhabditis elegans and in Escherichia coli wherein the plasmid, lacking a nucleotide sequence coding for a eukaryotic protein or a nucleic acid molecule, has the nucleotide sequence SEQ ID NO: 1 or SEQ ID NO:2. 4. Plasmid vector for expression in Caenorhabditis elegans and in Escherichia coli comprising in the 5' to 3' direction of transcription operably linked to each other a heat shock promoter nucleotide sequence, a synthetic intron nucleotide sequence containing a Shine-Dalgamo sequence, a multiple cloning site containing a nucleic acid molecule or a nucleotide sequence coding for a eukaryotic protein, a nucleotide sequence coding for a protease cleavage site, optionally a nucleotide sequence coding for a fluorescent protein, optionally a nucleotide sequence coding for a nuclear localization signal or a secretion signal, a nucleotide sequence coding for a recognizable tag and a nucleotide sequence coding for termination of translation so as to express a eukarvotic protein or nucleic acid molecule in Caenorhabditis elegans and in Escherichia coli wherein the plasmid, lacking a nucleotide sequence coding for a eukaryotic protein or a nucleic acid molecule, has the nucleotide sequence SEQ ID NO:9 or SEQ ID NO:10. 5. Plasmid vector according to claim 1, wherein the plasmid, lacking a nucleotide sequence coding for a eukaryotic protein or a nucleic acid molecule, has the nucleotide sequence SEQ ID NO: 1. 6. Plasmid vector according to claim 1, wherein the plasmid, lacking a nucleotide sequence coding for a eukaryotic protein or a nucleic acid molecule, has the nucleotide sequence SEQ ID NO: 2.

Details for Patent 7,741,098

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2039-03-29
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2039-03-29
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2039-03-29